GARP Research Maintains a 'Neutral' on Qiagen NV (QGEN); Q1 Review
Tweet
Share
E-mailGet Alerts QGEN Hot Sheet
Price: $42.81 -0.33%
Rating Summary:
14 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Rating Summary:
14 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Join SI Premium – FREE
GARP Research maintains a 'Neutral' on Qiagen NV (NASDAQ: QGEN).
Analyst, Alastair Mackay, said, "Sales grew 12% in the quarter, mostly due to two recent acquisitions. HPV revenue was flat, with competition leading to share erosion. QIAsymphony placements remain strong."
"The company is expanding into clinical trial genotyping, expression profiling, forensics, and veterinary applications. However, growth may be constrained by weakness in government- and pharma- funded R&D, while competition in HPV testing is heating up."
For an analyst ratings summary and ratings history on Qiagen NV click here. For more ratings news on Qiagen NV click here.
Shares of Qiagen NV closed at $16.83 yesterday.
Analyst, Alastair Mackay, said, "Sales grew 12% in the quarter, mostly due to two recent acquisitions. HPV revenue was flat, with competition leading to share erosion. QIAsymphony placements remain strong."
"The company is expanding into clinical trial genotyping, expression profiling, forensics, and veterinary applications. However, growth may be constrained by weakness in government- and pharma- funded R&D, while competition in HPV testing is heating up."
For an analyst ratings summary and ratings history on Qiagen NV click here. For more ratings news on Qiagen NV click here.
Shares of Qiagen NV closed at $16.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- B.Riley Downgrades Lantheus Holdings (LNTH) to Neutral
- Deutsche Bank Downgrades Workday (WDAY) to Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
